Quest Diagnostics
DGX
#1092
Rank
C$28.25 B
Marketcap
C$252.70
Share price
-0.85%
Change (1 day)
13.67%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2025 (TTM): C$1.80 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are C$10.85 Billion. In 2024 the company made an earning of C$1.62 Billion, an increase over its 2023 earnings that were of C$1.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.80 B11.04%
2024 C$1.62 B3.98%
2023 C$1.56 B-8.5%
2022 C$1.70 B-52.48%
2021 C$3.59 B37.95%
2020 C$2.60 B75.09%
2019 C$1.48 B16.2%
2018 C$1.28 B-10.1%
2017 C$1.42 B-5.16%
2016 C$1.50 B-1.54%
2015 C$1.52 B31%
2014 C$1.16 B-37.52%
2013 C$1.86 B26.93%
2012 C$1.46 B24.01%
2011 C$1.18 B-27.7%
2010 C$1.63 B-3.55%
2009 C$1.69 B19.59%
2008 C$1.42 B12.54%
2007 C$1.26 B-11.7%
2006 C$1.42 B13.49%
2005 C$1.25 B9.02%
2004 C$1.15 B13.19%
2003 C$1.02 B36.03%
2002 C$0.75 B63.07%
2001 C$0.46 B65.49%
2000 C$0.27 B1297.84%
1999 C$19.89 M-73.37%
1998 C$74.72 M-384.21%
1997 -C$26.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
C$1.84 B 3.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-C$2.66 Million-100.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.16 Billion-108.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$10.86 Million-100.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$57.67 M-96.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$0.74 B-57.95%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands